C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2004
10/26/2004	US6809235 Heat stable mutants of starch biosynthesis enzymes
10/26/2004	US6809233 Nucleotide sequences coding transport protein for use as tool in the transport of proteins in cells
10/26/2004	US6809232 Methods and compositions for the introduction of molecules into cells
10/26/2004	US6809189 Apoptin-associating protein
10/26/2004	US6809183 Polypeptide for use in the generation of disease resistant plants
10/26/2004	US6809178 Polypeptide for use in the treatment of addison's disease
10/26/2004	US6809117 Therapeutic uses of nitric oxide inhibitors
10/26/2004	US6809085 Adherent N,O-Carboxymethylchitosan drug delivery devices for moist tissue and methods of their use
10/26/2004	US6808922 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
10/26/2004	US6808912 For diagnosis/therapy of inflammation, cancer, arteriosclerosis, and psoriasis
10/26/2004	US6808905 Lentiviral vectors encoding clotting factors for gene therapy
10/26/2004	US6808904 Herbicide-tolerant protox genes produced by DNA shuffling
10/26/2004	US6808896 Generation of a genetically engineered cell; obtain cell, incubate with expression vector, transform, propagate cells, express vector, recover cell expressing reporter molecule
10/26/2004	US6808877 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection
10/26/2004	US6808705 For suppressing the proliferation of cancer cells
10/26/2004	US6808702 Repopulation of cellular components (neurons, muscles, tissues); for treatment of degenerative, immunologic/ inflammatory, neoplastic, and idiopathic conditions of the gastrointestinal tract
10/26/2004	CA2261999C Invertase inhibitor
10/21/2004	WO2004090126A2 Phosphodiesterase 10a7 isoforms and methods of use
10/21/2004	WO2004090122A1 Tongue epithelium-origin cell line kt-1 and use thereof
10/21/2004	WO2004090121A2 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
10/21/2004	WO2004090120A2 Stem cells having increased sensitivity to sdf-1 and methods of generating and using same
10/21/2004	WO2004090119A1 A method of producing nuclear transfer embryonic stem cell by somatic cell nuclear transplantation technique
10/21/2004	WO2004090115A2 Renilla gfp mutants with increased fluorescent intensity and special shift
10/21/2004	WO2004090110A2 Compositions and methods for the control, differentiation and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway
10/21/2004	WO2004090096A2 Methods for neural differentiation of embryonic stem cells using protease passaging techniques
10/21/2004	WO2004090095A2 Generation of human regulatory t cells by bacterial toxins for the treatment of inflammatory disorders
10/21/2004	WO2004090092A1 Incubator and method of cell culturing
10/21/2004	WO2004090091A2 Body with a culture surface for in-vitro propagation of cells
10/21/2004	WO2004089980A2 Therapeutic cancer vaccine
10/21/2004	WO2004089439A2 Elective collection and banking of autologous peripheral blood stem cells
10/21/2004	WO2004089302A2 Posh polypeptides, complexes and related methods
10/21/2004	WO2004089292A2 Immunomodulatory agents for treatment of inflammatory diseases
10/21/2004	WO2004089282A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/21/2004	WO2004076620A9 Human antibodies specific for interleukin 15 (il-15)
10/21/2004	WO2004072305A3 Atlastin
10/21/2004	WO2004056976A3 Process for coating cell-culture support
10/21/2004	WO2004050029A3 Novel activated polyethylene glycol compounds
10/21/2004	WO2004044142A3 Mesenchymal stem cells and methods of use thereof
10/21/2004	WO2004042023B1 Stem cell libraries
10/21/2004	WO2004040973A3 Organellar targeting of rna and its use in the interruption of environmental gene flow
10/21/2004	WO2004034013A3 Genotoxicity analysis
10/21/2004	WO2004022764A3 Use of malate dehydrogenase for nadh regeneration
10/21/2004	WO2004013275A8 Stem cells derived from adipous tissue and differentiated cells derived from said cells
10/21/2004	WO2003102197A8 Transgenic plants with controlled distribution of a trait to progeny
10/21/2004	WO2003027266A3 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
10/21/2004	WO1995027066A9 Dna encoding ubiquitin conjugating enzymes
10/21/2004	US20040210955 Preparation of spermatozoa for ICSI-mediated transgenesis and methods of using the same
10/21/2004	US20040210953 Lysozyme transgenic ungulates
10/21/2004	US20040210040 Monoclonal antibodies for use in the prevention and treatment of cell proliferative and skin disorders; immunotherapy; antitumor agents
10/21/2004	US20040210038 Il-1 eta DNA and polypeptides
10/21/2004	US20040209840 Manipulation of arterial-venous identity
10/21/2004	US20040209816 Treatment for diabetes
10/21/2004	US20040209801 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; kits
10/21/2004	US20040209363 Methods and compositions for modulating T cell activation and uses thereof
10/21/2004	US20040209361 UV-cross-linked PVA-based polymer particles for cell culture
10/21/2004	US20040209360 ultraviolet radiation crosslinkable hydrogel containing polyvinyl alcohol based multicomponent biological scaffold (with nutrients entrapped within) for use in propagating cell masses; tissue engineering and grafting; improved cell adhesion; sustained release
10/21/2004	US20040209359 Freeze-dried biocompatible matrix/biological scaffold comprising plasma proteins for use as implants in tissue engineering and biotechnology; wound healing agents
10/21/2004	US20040209357 Hematopoietic stem cells treated by in vitro fucosylation and methods of use
10/21/2004	US20040209356 incubating isomaltulose with sorbitol dehydrogenase; host cells
10/21/2004	US20040209346 Intermittent immersion vessel apparatus and process for plant propagation
10/21/2004	US20040209345 cyanide resistant; cultured from rhodococcus; for producing 2-hydroxy-4-methylthiobutyroamide from hydroxy nitrile compounds
10/21/2004	US20040209318 Reagents and methods for the detection and quantification of vancomycin in bilogical fluids
10/21/2004	US20040209314 Comprises multimer of major histocompatibility complex which binds peptide-specific CD8+ T lymphocyte populations for use as diagnostic components of immunoassay; immunotherapy
10/21/2004	US20040209313 T2R receptor binding assays that identify potential bitter taste modulatory compounds
10/21/2004	US20040209308 Methods of assaying receptor activity and constructs useful in such methods
10/21/2004	US20040209306 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
10/21/2004	US20040209286 Comprises nucleotide sequences coding g protein coupled receptors for use in identifying modulators of sweet taste transduction; food processing; improving palatability of low-calorie beverages through the development of new artificial sweeteners
10/21/2004	US20040209277 Transcription factor comprising zinc finger domain for use in controlling neuronal and osteoblast differentiation
10/21/2004	US20040209276 Heat resistant polymerases for use in propagation and replication of nucleic acids
10/21/2004	US20040209274 Constructs for Gene Expression Analysis
10/21/2004	US20040209264 Comprises nucleotide sequences coding daugther of legless protein for use in identifying modulator for tissue regeneration and repair and the treatment of blood disorders
10/21/2004	US20040209248 Comprises modified viral surface protein for use in detection and diagnosis of hepatitis infection
10/21/2004	US20040209238 Transgenic cells expressing preferential fusion proteins dynamically visualized through chronological photographing of dividing via fluorescence/laser microscopy
10/21/2004	US20040208920 injectable liposomal composition for delivery of large amounts of water-soluble substance comprises a plurality of liposomal vesicles having a high weight ratio of lipid to encapsulated water-soluble substance which is distributed over the liposomal vesicles; high efficiency of encapsulation
10/21/2004	US20040208900 mutant rabies virus comprising a rabies virus N protein that is not phosphorylated; central nervous system (CNS)
10/21/2004	US20040208881 B1k chain of laminin and methods of use
10/21/2004	US20040208878 Treatment of acute lung injury, fibrosis and metastasis with antagonists of alphabetav6
10/21/2004	US20040208876 Monoclonal antibodies to hepatocyte growth factor
10/21/2004	US20040208858 Causing mesenchymal stromal cells differentiate into neuron and oligodendrocyte cells to compensate for said neurological deterioration or damaged myelin; Parkinsons, Tay-Sachs, and Alzheimer*s disease; strokes, trauma,ganglioside storage dysfunction or demyelinization; multiple sclerosis
10/21/2004	US20040208857 Producing a donor-specific immunotolerance against transplanted tissue by administering embryonic stem cell-like cell lines (ECL) obtained from blastocysts and are transfected with genetic material of the donor, which codes for the major histocompatibility complex (MHC) haplotypes
10/21/2004	US20040208852 Inoculating a culture withectomycorrhizal fungus; adjoining layer of culture medium to a soil; inserting root and cultivating;
10/21/2004	DE10317008A1 New recombinant equine herpes (EHV) virus free of heterologous elements, and where protein gM has been deleted, useful as a vaccine for treating or preventing EHV infections
10/21/2004	DE10314363A1 Altering the size and morphology (animal) cells so that they simulate human cells and can be used for calibration of blood cell counters, comprises treating the cells with one or more specific chemicals e.g., polyethylene glycol
10/21/2004	DE102004017860A1 Verfahren und Einrichtung zur Zellkultivierung sowie Zellkulturträger Method and apparatus for cell culture and cell culture carriers
10/21/2004	CA2809195A1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
10/21/2004	CA2784829A1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
10/21/2004	CA2563393A1 Ml - iap peptides induce anti-melanoma cytotoxic t-cell response
10/21/2004	CA2548580A1 Elective collection and banking of autologous peripheral blood stem cells
10/21/2004	CA2521402A1 Pectate lyases, nucleic acids encoding them and methods for making and using them
10/21/2004	CA2521039A1 Methods for neural differentiation of embryonic stem cells using protease passaging techniques
10/21/2004	CA2520866A1 Phosphodiesterase 2a and methods of use
10/21/2004	CA2520803A1 Phosphodiesterase 10a7 isoforms and methods of use
10/21/2004	CA2520023A1 Stem cells having increased sensitivity to sdf-1 and methods of generating and using same
10/21/2004	CA2519975A1 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
10/20/2004	EP1469316A1 Screening method
10/20/2004	EP1469079A1 Carbonly reductases, polynucleotides comprising DNA encoding the same, methods for producing the same,and methods for producing optically active alcohol utilizing the same
10/20/2004	EP1469074A1 Human calcium channel compositions and methods
10/20/2004	EP1469064A1 Expression of proteins in endothelial cells derived from precursor cells from cord blood
10/20/2004	EP1468676A2 Poly (vinyl alcohol) cryogel
10/20/2004	EP1468284A2 Method for measuring intracellular atp and/or gene expression

1 ... 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 ... 1827